Penserra Capital Management LLC Igm Biosciences, Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$27.59 - $66.39 $16,140 - $38,838	-585 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$57.98 - $96.6 $579 - $966	10 Added 1.74%	585 $48,000
Q1 2021 May 13, 2021	BUY	$71.56 - $121.23 $1,431 - $2,424	20 Added 3.6%	575 $44,000
Q4 2020 Feb 12, 2021	BUY	$47.41 - $115.03 $26,312 - $63,841	555 New	555 $49,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.